1-BROMO-9-NORADAMANTAN-3-CARBOXYLIC-ACID-ETHYLENE-KETAL
Compound with spectra: 1 NMR
| SpectraBase Compound ID | IK5WpfU3Z2K |
|---|---|
| InChI | InChI=1S/C12H15BrO4/c13-11-5-7-3-8(12(11)16-1-2-17-12)4-10(7,6-11)9(14)15/h7-8H,1-6H2,(H,14,15)/t7-,8-,10-,11-/m1/s1 |
| InChIKey | GHWZZARKCFFLAK-YJFSRANCSA-N |
| Mol Weight | 303.15 g/mol |
| Molecular Formula | C12H15BrO4 |
| Exact Mass | 302.015372 g/mol |
| Enantiomer InChIKey | GHWZZARKCFFLAK-UUTMEEIUSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
ETHYL-1-BETA-ETHOXY-5-BETA-(2'-HYDROXY-4'-METHOXYPHENYL)-7A-BETA-METHYL-2,3,3A-ALPHA,4,5,6,7,7A-OCTAHYDRO-1H-INDENE-4-ALPHA-CARBOXYLATE
Tetrahydro-1,3-dimethyl-2,4-dioxo-5-carbomethoxy-7-tert-butyl-pyrido(2,3-D)pyrimidine
No Name
(7R)-3-Benzyloxy-7-Acetoxy-4,4,8-trimethylbicyclo[6.4.0]dodec-9-en-2,6,11-trione
(7S,8R,8'R,4''S,5'',S7''S,10''S)-9-O-(11-HYDROXY-EUDESMAN-4-YL)-DIHYDRO-SESAMIN
acetamide, N-(5-chloro-2-methoxyphenyl)-2-[[2-[2-(3,5-dimethyl-1H-pyrazol-4-yl)ethyl][1,2,4]triazolo[1,5-c]quinazolin-5-yl]thio]-
Carbonic acid, 9,9-dimethyl-8-oxospiro[bicyclo[3.3.1]non-6-ene-3,2'-[1,3]dioxolan]-6-yl 2-propenyl ester, (.+-.)-
CTZFHFLMJMLVSI-UHFFFAOYSA-N
(1-S)-1-[2-(1,3-DIOXOLAN-2-YL)-PHENYL]-2,2,2-TRIFLUOROETHYL_4,7,7-TRIMETHYL-3-OXO-2-OXABICYCLO-[2.2.1]-HEPTANE-1-CARBOXYLATE
5-(3,4-dimethoxyphenyl)-N-methyl-7-(trifluoromethyl)-N-[4-(trifluoromethyloxy)phenyl]pyrazolo[1,5-a]pyrimidine-2-carboxamide
| Title | Journal or Book | Year |
|---|---|---|
| Effect of Remote Substitution on Face Selection in Addition Reactions of Nor- and Homoadamantan-9-ones and of Several Analogues | The Journal of Organic Chemistry | 1998 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.